Block Listing Six Monthly Return

Source: RNS
RNS Number : 6731M
Aquis Exchange PLC
18 November 2024
 

BLOCK LISTING SIX MONTHLY RETURN

 

INFORMATION PROVIDED ON THIS FORM MUST BE TYPED OR PRINTED ELECTRONICALLY AND PROVIDED TO A PIP.

 

(Note: Italicised terms have the same meaning as given in the UK Listing Rules.)

Date: 19 November 2024

 

Name of applicant:

Aquis Exchange Plc

Name of scheme:

2020 EMI Option Scheme

Period of return:

From:

17/05/2024

To:

18/11/2024

Balance of unallotted securities under scheme(s) from previous return:

534,917 ordinary shares of 10p each.   

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

nil

Less:  Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G):

29,000 ordinary shares of 10p each

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

505,917 ordinary shares of 10p each.

 

Name of contact:

Philip Olm

Telephone number of contact:

+44 2035 976 375

 

Enquiries:

 

Aquis Exchange PLC

Alasdair Haynes, CEO

Richard Fisher, CFO

Adele Gilbert, Head of Marketing & Investor Relations

 

Tel: +44 (0)20 3597 6329

investorrelations@aquis.eu

Investec Bank plc (Nominated Adviser and Broker)

David Anderson

St John Hunter

 

Tel: +44 (0)20 7597 5970

Canaccord Genuity Limited (Joint Broker)

Emma Gabriel

George Grainger 

 

 Tel: +44 (0) 20 7523 8000

  

 

VSA Capital Limited (AQSE Corporate Adviser)

Andrew Raca

 

Tel: +44(0)20 3005 5000

 

 

About Aquis Exchange PLC

Aquis Exchange PLC ("Aquis") is Europe's challenger exchange, creating better markets for a modern economy. Aquis has market-leading technology and innovative rules for trading, and offer primary listings and secondary trading of equities, along with global licensing of proprietary technology.

Aquis consists of four divisions:

Aquis Markets operates lit and dark order books, covering 16 European markets. For its lit books, Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Technologies is the software and technology division of Aquis. It focuses on building better markets via the creation and licensing of cutting-edge, cost-effective exchange infrastructure technology and services, including matching engine and trade surveillance solutions.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex'; the Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Data generates revenue from the sale of data derived from Aquis Markets and Aquis Stock Exchange to non-Member market participants.

Aquis is authorised and regulated by the UK Financial Conduct Authority and France's Autorité de contrôle prudentiel et de résolution and L'Autorité des marchés financiers to operate Multilateral Trading Facility businesses in the UK & Switzerland markets and in EU27 markets respectively. Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the AIM Market (AIM) of the LSE. For more information, please go to www.aquis.eu.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRQKFBKABDDFDD